$3.41
0.041.19%
At Close: -
$3.68
0.277.92%
After Hours: Jul 2, 7:42 AM EDT
15 minutes delayed
Avenue Therapeutics
ATXINASDAQ
Avenue Therapeutics (NASDAQ:ATXI) Stock, Earnings Estimates, EPS, And Revenue
Avenue Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-7.500
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Avenue Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATXI | Avenue Therapeutics | -$39.00 | -$7.50 | — | — | $0.00 | — | — | — | 08/08/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$101.57 | -$9.00 | -$15.40 | -71.11% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$92.25 | -$7.50 | $2.25 | 130.00% | $0.00 | — | $0.00 | — | 03/18/2024 | Get Alert |
| ATXI | Avenue Therapeutics | -$33.75 | -$19.50 | $4.50 | 123.08% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$33.75 | -$21.75 | -$39.00 | -79.31% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$157.50 | — | -$102.75 | — | $0.00 | — | $0.00 | — | 05/12/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$56.25 | — | -$92.25 | — | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| ATXI | Avenue Therapeutics | -$59.25 | — | -$33.75 | — | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | — | -$33.75 | — | $0.00 | — | $0.00 | — | 08/15/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | — | -$157.50 | — | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | — | -$56.25 | — | $0.00 | — | $0.00 | — | 03/25/2022 | Get Alert |
| ATXI | Avenue Therapeutics | -$67.50 | -$56.25 | -$56.25 | 0.00% | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$123.75 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$90.00 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$371.25 | -$78.75 | -$67.50 | 14.29% | $0.00 | — | $0.00 | — | 03/31/2021 | Get Alert |
| ATXI | Avenue Therapeutics | -$157.50 | — | -$67.50 | — | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$483.75 | — | -$123.75 | — | $0.00 | — | $0.00 | — | 08/14/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$922.50 | -$191.25 | -$90.00 | 52.94% | $0.00 | — | $0.00 | — | 05/11/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$416.25 | — | -$371.25 | — | $0.00 | — | $0.00 | — | 03/30/2020 | Get Alert |
| ATXI | Avenue Therapeutics | -$281.25 | -$315.00 | -$157.50 | 50.00% | $0.00 | — | $0.00 | — | 11/04/2019 | Get Alert |
| ATXI | Avenue Therapeutics | -$506.25 | — | -$483.75 | — | $0.00 | — | $0.00 | — | 08/14/2019 | Get Alert |
Avenue Therapeutics (ATXI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-15.40 | $-9.00 | -71.1 % |
| Dec 2023 | 2024-03-18 | $2.25 | $-7.50 | 130.0 % |
| Sep 2023 | 2023-11-13 | $4.50 | $-19.50 | 123.1 % |
| Jun 2023 | 2023-08-10 | $-39.00 | $-21.75 | -79.3 % |
Avenue Therapeutics (ATXI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
Avenue Therapeutics (ATXI) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Avenue Therapeutics (NASDAQ:ATXI)?
The Actual EPS was $-15.40, which missed the estimate of $-9.00.
What were Avenue Therapeutics’s (NASDAQ:ATXI) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.